Paul G. Solari

597 total citations
20 papers, 443 citations indexed

About

Paul G. Solari is a scholar working on Hematology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul G. Solari has authored 20 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Physiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul G. Solari's work include Hemophilia Treatment and Research (8 papers), Asthma and respiratory diseases (6 papers) and Respiratory and Cough-Related Research (4 papers). Paul G. Solari is often cited by papers focused on Hemophilia Treatment and Research (8 papers), Asthma and respiratory diseases (6 papers) and Respiratory and Cough-Related Research (4 papers). Paul G. Solari collaborates with scholars based in United States, United Kingdom and Germany. Paul G. Solari's co-authors include Benjamin Trzaskoma, Allan T. Luskin, Karin Rosén, William W. Busse, Bradley E. Chipps, Theodore A. Omachi, Dennis K. Ledford, Jonathan Tay, James L. Zazzali and Stacy E. Croteau and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Paul G. Solari

20 papers receiving 425 citations

Peers

Paul G. Solari

PHYSI

PRM

HEMAT

DERMA

Janice Mooney United Kingdom

Romi Bloom United States

Alex Wing Kwan Leung Hong Kong

Santiago Bernal‐Macías Colombia

Laurence Gozalo United States

Julia A. Ford United States

Lim To Malaysia

Amy Joseph United States

Warren Hyer United Kingdom

Randall Winnette United States

Janice Mooney United Kingdom

Paul G. Solari

78 ×0.3

PHYSI

210 ×1.2

PRM

44 ×0.4

HEMAT

8 ×0.1

6 ×0.1

DERMA

Citations per year, relative to Paul G. Solari Paul G. Solari (= 1×) peers Janice Mooney

Countries citing papers authored by Paul G. Solari

Since Specialization

Citations

This map shows the geographic impact of Paul G. Solari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul G. Solari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul G. Solari more than expected).

Fields of papers citing papers by Paul G. Solari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul G. Solari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul G. Solari. The network helps show where Paul G. Solari may publish in the future.

Co-authorship network of co-authors of Paul G. Solari

This figure shows the co-authorship network connecting the top 25 collaborators of Paul G. Solari. A scholar is included among the top collaborators of Paul G. Solari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul G. Solari. Paul G. Solari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yilin, et al.. (2023). Health care costs and resource use of managing hemophilia A: A targeted literature review. Journal of Managed Care & Specialty Pharmacy. 29(6). 647–658. 10 indexed citations

Recht, Michael, et al.. (2022). Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset. SHILAP Revista de lepidopterología. 3(2). 341–352. 5 indexed citations

Thornburg, Courtney D., David Hinds, Er Chen, et al.. (2021). Health care costs and resource utilization among commercially insured adult patients with hemophilia A managed with FVIII prophylaxis in the United States. Journal of Managed Care & Specialty Pharmacy. 28(4). 449–460. 8 indexed citations

Hinds, David, Edmund J. Pezalla, Dunlei Cheng, et al.. (2021). Health insurance coverage and switching among people with hemophilia A in the United States. Journal of Managed Care & Specialty Pharmacy. 28(2). 232–243. 1 indexed citations

Croteau, Stacy E., Anita Chawla, Paul G. Solari, et al.. (2021). Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis. Journal of Managed Care & Specialty Pharmacy. 27(3). 316–326. 21 indexed citations

Swindle, Jason, et al.. (2019). Healthcare costs among patients with hemophilia A treated with factor replacement or bypassing agents. Current Medical Research and Opinion. 35(8). 1433–1440. 3 indexed citations

Lyons, Jennifer G., Yaping Xu, Greg Ridgeway, et al.. (2018). Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database. Value in Health. 21(9). 1098–1103. 15 indexed citations

Kruse‐Jarres, Rebecca, Michael U. Callaghan, Stacy E. Croteau, et al.. (2017). Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2). Blood. 130(Suppl_1). 89–89. 43 indexed citations

Chipps, Bradley E., Robert S. Zeiger, Allan T. Luskin, et al.. (2017). Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO. Annals of Allergy Asthma & Immunology. 119(6). 524–532.e2. 23 indexed citations

10.

Luskin, Allan T., Evgeniya Antonova, Michael S. Broder, et al.. (2017). Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio. Journal of Managed Care & Specialty Pharmacy. 23(11). 1117–1124. 9 indexed citations

11.

Ledford, Dennis K., William W. Busse, Benjamin Trzaskoma, et al.. (2016). A randomized multicenter study evaluating Xolair persistence of response after long-term therapy. Journal of Allergy and Clinical Immunology. 140(1). 162–169.e2. 146 indexed citations

12.

Zazzali, James L., Allen P. Kaplan, Marcus Maurer, et al.. (2016). Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Annals of Allergy Asthma & Immunology. 117(4). 370–377.e1. 20 indexed citations

13.

Cherepanov, Dasha, Karina Raimundo, Eunice Chang, et al.. (2015). Validation of an ICD-9–based claims algorithm for identifying patients with chronic idiopathic/spontaneous urticaria. Annals of Allergy Asthma & Immunology. 114(5). 393–398. 25 indexed citations

14.

Janson, Susan, Paul G. Solari, Benjamin Trzaskoma, et al.. (2015). Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma. Annals of Allergy Asthma & Immunology. 114(6). 516–521.e2. 19 indexed citations

15.

Raimundo, Karina, Iftikhar Hussain, Syed M. Rehman, et al.. (2014). Validation Of An Icd-9-Based Claims Algorithm For Identifying Patients With Chronic Idiopathic/ Spontaneous Urticaria. Value in Health. 17(3). A283–A283. 1 indexed citations

16.

Busse, William W., Theodore A. Omachi, Janice Canvin, et al.. (2014). Evaluating omalizumab persistency of response after long-term therapy (XPORT). European Respiratory Journal. 44(Suppl 58). P3485–P3485. 9 indexed citations

17.

Zeiger, Robert S., Michael Schätz, Qiaowu Li, et al.. (2014). Real-Time Asthma Outreach Reduces Excessive Short-acting β2-Agonist Use: A Randomized Study. The Journal of Allergy and Clinical Immunology In Practice. 2(4). 445–456.e5. 20 indexed citations

18.

Schätz, Michael, Michael S. Broder, Eunice Chang, et al.. (2009). Asthma quality-of-care measures using administrative data: identifying the optimal denominator. Annals of Allergy Asthma & Immunology. 102(2). 98–102. 5 indexed citations

19.

Mackowiak, John I., et al.. (2004). Triptan Therapy Impacts Health and Productivity. Journal of Occupational and Environmental Medicine. 46(8). 812–817. 14 indexed citations

20.

Tay, Jonathan, et al.. (1997). Malignant Eccrine Spiradenoma. American Journal of Clinical Oncology. 20(6). 552–557. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact